by Doug Oliver | Jun 12, 2017 | Bioethics, News & Opinions, Policy
I just spent a week at Wake Forest University Institute for Regenerative Medicine. I enjoyed the experience of being immersed in all things tissue-regeneration, bio-printing, scaffold development, and, especially, the unique collaboration model they have with private...
by Doug Oliver | May 17, 2017 | News & Opinions
What happens when a cell-based therapy gets characterized as a “cure”? A Patient’s Answer May Be Surprising. How is using the word “cure” at this stage of our clinical translation of regenerative medicine likely to impact patients the most? I’ve considered...
by Doug Oliver | Apr 24, 2017 | News & Opinions, Policy
Everybody loves a good story. It doesn’t really matter if it’s true or false or somewhere in between. For stories, the truth is found in the telling – in the narrative. When we hear a story, we’re as much captured by the way it’s told, the meaning behind the...
